CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
CRWV has a planned sale of 200,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, to be effected on or after 07/28/2026 on NASDAQ. These shares were acquired via a Preferred Stock Conversion dated 02/25/2019.
Over the prior three months, the disclosure lists multiple Rule 10b5-1 sales of CRWV common stock by Michael Intrator and Omnadora Capital LLC in large blocks, often around 200,000 and 107,692 shares, as well as a notable transaction by Fidelity Charitable involving 99,134 shares.
CRWV shareholders filed a Form 144 covering proposed sales of 107,692 shares of common stock, with an indicated market value of $7,623,516.68. The filing also lists recent Rule 10b5-1 trading activity over the past three months by Michael Intrator, Omnadora Capital LLC, and others, including multiple sales of 200,000 shares of common stock on various dates.
The notice relates to planned sales of 25,000 shares of common stock of CRWV, to be effected through Morgan Stanley Smith Barney LLC Executive Financial Services after 07/27/2026. These shares are identified as Founders Shares originally acquired on 02/25/2019. The notice also lists extensive recent Rule 10b5-1 plan sales over the past three months by Brannin McBee, Meghan Bennett and several related trusts, with multiple transactions of up to 144,000 shares per trade and multi‑million‑dollar gross proceeds on each date.
CRWV has a planned sale of up to 25,000 shares of common stock, to be effected through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate value of $1,797,000.00 and the shares listed on NASDAQ. These are identified as Founders Shares originally dated February 25, 2019. The disclosure also lists numerous Rule 10b5-1 plan sales of common stock during June and July 2026 by Brannin McBee, Meghan Bennett and several related trusts and entities, each with specified share amounts and dollar values.
CRWV insiders filed a notice to sell 3,000 shares of common stock through Morgan Stanley Smith Barney’s Executive Financial Services, with an aggregate value of $215,640.00. The filing also lists extensive Rule 10b5-1 programmed sales by Brannin McBee, Meghan Bennett and related trusts from June to July 2026, including multiple recurring blocks of 144,000 shares sold on several trading days.
CRWV insiders have filed a notice to sell 40,000 shares of common stock through Morgan Stanley Smith Barney LLC’s Executive Financial Services, with an aggregate market value of $2,875,200.00, under Rule 144. The filing also lists multiple recent Rule 10b5-1 programmed sales of common stock by Brannin McBee, Meghan Bennett, related trusts, and grantor-retained annuity trusts between June and July 2026, each specifying dates, share amounts, and dollar proceeds.
CRWV insiders and related entities filed to sell 144,000 shares of common stock through Morgan Stanley Smith Barney, with an indicated value of $10,350,720, beginning on or after July 27, 2026. The filing lists extensive prior Rule 10b5-1 common stock sales over the past three months by Brannin McBee, Meghan Bennett, and several associated trusts.
A holder of CRWV common stock submitted a notice of proposed sale under Form 144. The filing lists 12,500 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $898,500.00, originally acquired as Founders Shares on February 25, 2019.
The notice also details prior Rule 10b5-1 trading plan sales of CRWV common stock during the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities, each showing dates, share amounts and dollar values of these completed sales.
CRWV has a notice of proposed sale under Form 144 in which an affiliated holder plans to sell 500 common shares classified as Founders Shares through Morgan Stanley Smith Barney LLC, with an indicated aggregate value of $35,940.00. The disclosure also lists numerous prior Rule 10b5-1 common stock sales in June and July 2026 by Brannin McBee, Meghan Bennett and related trusts, with individual transactions of up to 144,000 shares and proceeds in the multi-million-dollar range.
CoreWeave, Inc. director, CEO and President Michael N. Intrator reported a derivative conversion and multiple stock sales dated July 21, 2026. An indirect holding of 107,692 shares of Class B Common Stock held through Omnadora Capital LLC was converted into 107,692 shares of Class A Common Stock.
On the same date he executed multiple Rule 10b5-1 plan sales totaling 307,692 shares of Class A Common Stock in open‑market or private transactions at weighted‑average prices reported between $75.5407 and $80.0839 per share, with individual trade ranges from $74.93 to $80.35. He continues to report substantial Class B holdings convertible into Class A, including 21,867,489 Class B shares directly and additional Class B shares indirectly through a GRAT, family trusts and his spouse, with certain indirect interests disclaimed except to the extent of his pecuniary interest.